Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years.
Postpartum depression affects an estimated 400,000 people a year, and while it often ends on its own within a couple weeks, it can continue for months or even years.
The US Food and Drug Administration on Friday approved for the first time a pill to treat postpartum depression, a condition believed to affect around half a million women in the country every year.
WASHINGTON (AP) — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of
The U.S. Food and Drug Administration (FDA) approved a milestone first pill treating postpartum depression (PPD), the agency wrote in a Friday press release.
Federal health officials have approved the first pill to specifically treat depression after childbirth. Postpartum depression affects thousands of new mothers in the U.S. each year. The Food and Drug
Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop …
WASHINGTON — Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each
WASHINGTON -- Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Postpartum depression is one of the most common complications of childbirth, affecting about a half million Americans each year. It’s among the leading causes of pregnancy-related death. Now, the FDA has approved the first pill for treating postpartum depression.
Postpartum depression affects nearly 400,000 people a year. While it often resolves within a couple of weeks, it can continue for months or years if left untreated.
The Food and Drug Administration announced Friday its approval of the new drug zuranolone for postpartum depression. The once-daily pill, meant for short-term use, may help those who struggle with the serious, sometimes life-threatening condition.
Postpartum depression affects as many as 1 in 7 women in the U.S., though there are just two treatments approved for it. Experts say the newest could be a game-changer — depending on its price tag.
For the first time ever, the FDA has approved a pill to help women suffering from postpartum depression, a condition that affects thousands of new mothers in the U.S. each year.
Showing the first 25 of 26 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
A pill to treat postpartum depression is approved by the FDA | Since Then
